Effect of Litsea lancifolia leaf extract on glucose transporter 4 translocation and glucose uptake in 3T3L1 cell line

Murad Alsawalha, Abeer Mohammed Al-Subaie, Reem Yousuf Al-Jindan, Srinivasa Rao Bolla, Janardhana Papayya Balakrishna, Padma Kanchi Ravi, Shiva Shankar Reddy Gollapalli, Vishnu Priya Veeraraghavan, Aruthra Arumugam Pillai, Joel Palpath Joseph, Surapaneni Krishna Mohan

Research output: Contribution to journalArticle

Abstract

Background: Numerous synthetic drugs have been recommended as a remedy for diabetes, but their role in hypoglycemic effects are diverse. The side effects associated with these drugs due to their extended use led scientists to find unconventional medicines with no or little side effects. Aim: This study was aimed at assessment of in vitro antidiabetic activities of methanolic extract of Litsea lancifolia leaves by using 3T3L1 cell line. Materials and Methods: The cytotoxic effect of the leaf extract was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The glucose uptake-inducing capabilities and its correlation with glucose transporter 4 (GLUT4) translocation were measured by flow cytometry in 3T3L1 cells. In addition, the inhibitory effect of L. lancifolia leaf extract on α-amylase activity and α-glucosidase activity was determined by colorimetric methods. Results: Different concentrations of L. lancifolia leaf extract did not show any toxicity on 3T3L1 cells, after the treatment for 24h. On stimulation with leaf extract, 60.22% and 86.26% of 3T3L1 cells showed glucose uptake and GLUT4 expression, respectively. The colorimetric assays showed that the methanolic leaf extract of L. lancifolia has a significant inhibitory effect on the activity of α-amylase enzyme and α-glucosidase enzyme with inhibitory concentration (IC50) value of 248.65 μg/mL and 229.61 μg/mL, respectively. Conclusion: On the basis of the results of this study, it is evident that L. lancifolia leaf extract showed promising anti-diabetic effect when compared to the standard drugs metformin and acarbose and was nontoxic to 3T3L1 cells. Thus, it can be further investigated to recommend as a possible alternative treatment in antidiabetic applications.

Original languageEnglish
Pages (from-to)240-247
Number of pages8
JournalJournal of Pharmacy and Bioallied Sciences
Volume11
Issue number3
DOIs
Publication statusPublished - Jul 1 2019
Externally publishedYes

Fingerprint

Litsea
Facilitative Glucose Transport Proteins
Hypoglycemic Agents
Glucosidases
Glucose
Cells
Amylases
Cell Line
Assays
Pharmaceutical Preparations
Acarbose
Enzymes
Flow cytometry
Metformin
Medical problems
Medicine
Toxicity
Inhibitory Concentration 50
Catalyst activity
Flow Cytometry

Keywords

  • 3T3L1 cell line
  • Antidiabetic activity
  • glucose transporter 4 expression studies
  • glucosidase inhibition
  • Litsea lancifolia

ASJC Scopus subject areas

  • Bioengineering
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Effect of Litsea lancifolia leaf extract on glucose transporter 4 translocation and glucose uptake in 3T3L1 cell line. / Alsawalha, Murad; Al-Subaie, Abeer Mohammed; Al-Jindan, Reem Yousuf; Bolla, Srinivasa Rao; Balakrishna, Janardhana Papayya; Ravi, Padma Kanchi; Gollapalli, Shiva Shankar Reddy; Veeraraghavan, Vishnu Priya; Pillai, Aruthra Arumugam; Joseph, Joel Palpath; Mohan, Surapaneni Krishna.

In: Journal of Pharmacy and Bioallied Sciences, Vol. 11, No. 3, 01.07.2019, p. 240-247.

Research output: Contribution to journalArticle

Alsawalha, M, Al-Subaie, AM, Al-Jindan, RY, Bolla, SR, Balakrishna, JP, Ravi, PK, Gollapalli, SSR, Veeraraghavan, VP, Pillai, AA, Joseph, JP & Mohan, SK 2019, 'Effect of Litsea lancifolia leaf extract on glucose transporter 4 translocation and glucose uptake in 3T3L1 cell line', Journal of Pharmacy and Bioallied Sciences, vol. 11, no. 3, pp. 240-247. https://doi.org/10.4103/jpbs.JPBS_53_19
Alsawalha, Murad ; Al-Subaie, Abeer Mohammed ; Al-Jindan, Reem Yousuf ; Bolla, Srinivasa Rao ; Balakrishna, Janardhana Papayya ; Ravi, Padma Kanchi ; Gollapalli, Shiva Shankar Reddy ; Veeraraghavan, Vishnu Priya ; Pillai, Aruthra Arumugam ; Joseph, Joel Palpath ; Mohan, Surapaneni Krishna. / Effect of Litsea lancifolia leaf extract on glucose transporter 4 translocation and glucose uptake in 3T3L1 cell line. In: Journal of Pharmacy and Bioallied Sciences. 2019 ; Vol. 11, No. 3. pp. 240-247.
@article{249f8115abfa4d2c9139269bf31ddfaa,
title = "Effect of Litsea lancifolia leaf extract on glucose transporter 4 translocation and glucose uptake in 3T3L1 cell line",
abstract = "Background: Numerous synthetic drugs have been recommended as a remedy for diabetes, but their role in hypoglycemic effects are diverse. The side effects associated with these drugs due to their extended use led scientists to find unconventional medicines with no or little side effects. Aim: This study was aimed at assessment of in vitro antidiabetic activities of methanolic extract of Litsea lancifolia leaves by using 3T3L1 cell line. Materials and Methods: The cytotoxic effect of the leaf extract was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The glucose uptake-inducing capabilities and its correlation with glucose transporter 4 (GLUT4) translocation were measured by flow cytometry in 3T3L1 cells. In addition, the inhibitory effect of L. lancifolia leaf extract on α-amylase activity and α-glucosidase activity was determined by colorimetric methods. Results: Different concentrations of L. lancifolia leaf extract did not show any toxicity on 3T3L1 cells, after the treatment for 24h. On stimulation with leaf extract, 60.22{\%} and 86.26{\%} of 3T3L1 cells showed glucose uptake and GLUT4 expression, respectively. The colorimetric assays showed that the methanolic leaf extract of L. lancifolia has a significant inhibitory effect on the activity of α-amylase enzyme and α-glucosidase enzyme with inhibitory concentration (IC50) value of 248.65 μg/mL and 229.61 μg/mL, respectively. Conclusion: On the basis of the results of this study, it is evident that L. lancifolia leaf extract showed promising anti-diabetic effect when compared to the standard drugs metformin and acarbose and was nontoxic to 3T3L1 cells. Thus, it can be further investigated to recommend as a possible alternative treatment in antidiabetic applications.",
keywords = "3T3L1 cell line, Antidiabetic activity, glucose transporter 4 expression studies, glucosidase inhibition, Litsea lancifolia",
author = "Murad Alsawalha and Al-Subaie, {Abeer Mohammed} and Al-Jindan, {Reem Yousuf} and Bolla, {Srinivasa Rao} and Balakrishna, {Janardhana Papayya} and Ravi, {Padma Kanchi} and Gollapalli, {Shiva Shankar Reddy} and Veeraraghavan, {Vishnu Priya} and Pillai, {Aruthra Arumugam} and Joseph, {Joel Palpath} and Mohan, {Surapaneni Krishna}",
year = "2019",
month = "7",
day = "1",
doi = "10.4103/jpbs.JPBS_53_19",
language = "English",
volume = "11",
pages = "240--247",
journal = "Journal of Pharmacy and Bioallied Sciences",
issn = "0976-4879",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "3",

}

TY - JOUR

T1 - Effect of Litsea lancifolia leaf extract on glucose transporter 4 translocation and glucose uptake in 3T3L1 cell line

AU - Alsawalha, Murad

AU - Al-Subaie, Abeer Mohammed

AU - Al-Jindan, Reem Yousuf

AU - Bolla, Srinivasa Rao

AU - Balakrishna, Janardhana Papayya

AU - Ravi, Padma Kanchi

AU - Gollapalli, Shiva Shankar Reddy

AU - Veeraraghavan, Vishnu Priya

AU - Pillai, Aruthra Arumugam

AU - Joseph, Joel Palpath

AU - Mohan, Surapaneni Krishna

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Background: Numerous synthetic drugs have been recommended as a remedy for diabetes, but their role in hypoglycemic effects are diverse. The side effects associated with these drugs due to their extended use led scientists to find unconventional medicines with no or little side effects. Aim: This study was aimed at assessment of in vitro antidiabetic activities of methanolic extract of Litsea lancifolia leaves by using 3T3L1 cell line. Materials and Methods: The cytotoxic effect of the leaf extract was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The glucose uptake-inducing capabilities and its correlation with glucose transporter 4 (GLUT4) translocation were measured by flow cytometry in 3T3L1 cells. In addition, the inhibitory effect of L. lancifolia leaf extract on α-amylase activity and α-glucosidase activity was determined by colorimetric methods. Results: Different concentrations of L. lancifolia leaf extract did not show any toxicity on 3T3L1 cells, after the treatment for 24h. On stimulation with leaf extract, 60.22% and 86.26% of 3T3L1 cells showed glucose uptake and GLUT4 expression, respectively. The colorimetric assays showed that the methanolic leaf extract of L. lancifolia has a significant inhibitory effect on the activity of α-amylase enzyme and α-glucosidase enzyme with inhibitory concentration (IC50) value of 248.65 μg/mL and 229.61 μg/mL, respectively. Conclusion: On the basis of the results of this study, it is evident that L. lancifolia leaf extract showed promising anti-diabetic effect when compared to the standard drugs metformin and acarbose and was nontoxic to 3T3L1 cells. Thus, it can be further investigated to recommend as a possible alternative treatment in antidiabetic applications.

AB - Background: Numerous synthetic drugs have been recommended as a remedy for diabetes, but their role in hypoglycemic effects are diverse. The side effects associated with these drugs due to their extended use led scientists to find unconventional medicines with no or little side effects. Aim: This study was aimed at assessment of in vitro antidiabetic activities of methanolic extract of Litsea lancifolia leaves by using 3T3L1 cell line. Materials and Methods: The cytotoxic effect of the leaf extract was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The glucose uptake-inducing capabilities and its correlation with glucose transporter 4 (GLUT4) translocation were measured by flow cytometry in 3T3L1 cells. In addition, the inhibitory effect of L. lancifolia leaf extract on α-amylase activity and α-glucosidase activity was determined by colorimetric methods. Results: Different concentrations of L. lancifolia leaf extract did not show any toxicity on 3T3L1 cells, after the treatment for 24h. On stimulation with leaf extract, 60.22% and 86.26% of 3T3L1 cells showed glucose uptake and GLUT4 expression, respectively. The colorimetric assays showed that the methanolic leaf extract of L. lancifolia has a significant inhibitory effect on the activity of α-amylase enzyme and α-glucosidase enzyme with inhibitory concentration (IC50) value of 248.65 μg/mL and 229.61 μg/mL, respectively. Conclusion: On the basis of the results of this study, it is evident that L. lancifolia leaf extract showed promising anti-diabetic effect when compared to the standard drugs metformin and acarbose and was nontoxic to 3T3L1 cells. Thus, it can be further investigated to recommend as a possible alternative treatment in antidiabetic applications.

KW - 3T3L1 cell line

KW - Antidiabetic activity

KW - glucose transporter 4 expression studies

KW - glucosidase inhibition

KW - Litsea lancifolia

UR - http://www.scopus.com/inward/record.url?scp=85068857110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068857110&partnerID=8YFLogxK

U2 - 10.4103/jpbs.JPBS_53_19

DO - 10.4103/jpbs.JPBS_53_19

M3 - Article

AN - SCOPUS:85068857110

VL - 11

SP - 240

EP - 247

JO - Journal of Pharmacy and Bioallied Sciences

JF - Journal of Pharmacy and Bioallied Sciences

SN - 0976-4879

IS - 3

ER -